Related references
Note: Only part of the references are listed.CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell-mediated cytotoxicity
Eun Jae Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2022)
Chemokine networks modulating natural killer cell trafficking to solid tumors
Xue Yao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Natural Killer Cell Integrins and Their Functions in Tissue Residency
Michael J. Shannon et al.
FRONTIERS IN IMMUNOLOGY (2021)
Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-α-stimulated endothelial cells via the NF-κB/JNK/p38 MAPK signaling pathway
Xianjing Zheng et al.
ARCHIVES OF PHARMACAL RESEARCH (2021)
The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking
Yang Zhao et al.
CANCERS (2021)
Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics
Qingliang Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review
Cao Dai Phung et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sesamolin promotes cytolysis and migration activity of natural killer cells via dendritic cells
Jae Kwon Lee
ARCHIVES OF PHARMACAL RESEARCH (2020)
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghba et al.
CELL COMMUNICATION AND SIGNALING (2020)
Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Faslpr Mice
Hong Kyung Lee et al.
STEM CELLS INTERNATIONAL (2020)
From stem cell to immune effector: how adhesion, migration, and polarity shape T-cell and natural killer cell lymphocyte development in vitro and in vivo
Barclay J. Lee et al.
MOLECULAR BIOLOGY OF THE CELL (2020)
Setosphapyrone C and D accelerate macrophages cholesterol efflux by promoting LXRα/ABCA1 pathway
Ting Li et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives
Laurenz Nagl et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling
Dayoung Ryu et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Characterization of morphological changes of B16 melanoma cells under natural killer cell attack
Ji Sung Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
L-selectin: A Major Regulator of Leukocyte Adhesion, Migration and Signaling
Aleksander Ivetic et al.
FRONTIERS IN IMMUNOLOGY (2019)
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao et al.
MOLECULAR CANCER RESEARCH (2019)
Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
Hyung Sook Kim et al.
IMMUNE NETWORK (2019)
Support of Tumor Endothelial Cells by Chemokine Receptors
Nicole Salazar et al.
FRONTIERS IN IMMUNOLOGY (2019)
Active roles of dysfunctional vascular endothelium in fibrosis and cancer
Tien Hsu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion
Haaglim Cho et al.
CLINICAL CANCER RESEARCH (2018)
Role of Chemokines in Thyroid Cancer Microenvironment: is CXCL8 the Main Player?
Mario Rotondi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells
Juyoung Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Maria Georganaki et al.
FRONTIERS IN IMMUNOLOGY (2018)
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
Kun-Yu Teng et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Regulation of M1-type and M2-type macrophage polarization in RAW264.7 cells by Galectin-9
Ran Lv et al.
MOLECULAR MEDICINE REPORTS (2017)
CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms
Hong Kyung Lee et al.
SCIENTIFIC REPORTS (2017)
Cd226-/- natural killer cells fail to establish stable contacts with cancer cells and show impaired control of tumor metastasis in vivo
Ji Sung Kim et al.
ONCOIMMUNOLOGY (2017)
Gnb isoforms control a signaling pathway comprising Rac1, Plcβ2, and Plcβ3 leading to LFA-1 activation and neutrophil arrest in vivo
Helena Block et al.
BLOOD (2016)
Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis
Marko Roblek et al.
JOURNAL OF CONTROLLED RELEASE (2015)
CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow
Naoki Fujimura et al.
SCIENTIFIC REPORTS (2015)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
Talib Hassan Ali et al.
NATURE COMMUNICATIONS (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination
Ignacio Melero et al.
CLINICAL CANCER RESEARCH (2013)
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Yamila S. Rocca et al.
INNATE IMMUNITY (2013)
An evolving new paradigm: endothelial cells - conditional innate immune cells
Jietang Mai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Chemokine-triggered leukocyte arrest: force-regulated bi-directional integrin activation in quantal adhesive contacts
Ronen Alon et al.
CURRENT OPINION IN CELL BIOLOGY (2012)
CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice
Mary J. G. van Helden et al.
PLOS ONE (2012)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
Novel functions of the CD34 family
Julie S. Nielsen et al.
JOURNAL OF CELL SCIENCE (2008)
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
Tonya C. Walser et al.
CANCER RESEARCH (2006)
Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis
Y Terashima et al.
NATURE IMMUNOLOGY (2005)
Tissue-specific effect of estradiol on endothelial cell-dependent lymphocyte recruitment
HS Murphy et al.
MICROVASCULAR RESEARCH (2004)
Cytokine requirements for the growth and development of mouse NK cells in vitro
JA Toomey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)